Projects per year
Y-biologics: A Phase 1, Open-Label, Multicenter, Single Arm, Dose-Escalation/Dose-Expansion Study of YBL-006 in Patients with Advanced Solid Tumors
1/06/20 → 30/04/23
CONTESSA: A Multicenter, Phase 2 Study of Tesetaxel plus Three Different PD-(L)1 Inhibitors in Patients with Triple-Negative, Locally Advanced or Metastatic Breast Cancer and Tesetaxel Monotherapy in Elderly Patients with HER2 Negative, Locally Advanced or Metastatic Breast Cancer
Sabanathan, D., Park, J., Gilchrist, J., Rai, M. & Chapman, N.
1/05/20 → 31/12/21
DNA aptamers targeting endothelial RAS mutants for vascular drug delivery in brain arteriovenous malformations
1/01/20 → 31/12/20
1/09/19 → 1/12/22
1/01/19 → 31/12/20
A Phase 1B/2 study to evaluate safety and anti-tumour activity of AVELUMAB in combination with POLY (ADENOSINE DIPHOSPHATE [ADP]-RIBOSE) POLYMERASE (PARP) inhibitor TALAZOPARIB in patients with locally advance or metastatic solid tumours
Sabanathan, D., Kefford, R., Butala, R. & Cunningham, J.
19/07/18 → 21/06/23